Academic Journal

Wearable Movement-Tracking for Prodromal Parkinson's Disease Detection: A Cross-Country Validation Study.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Wearable Movement-Tracking for Prodromal Parkinson's Disease Detection: A Cross-Country Validation Study.
Συγγραφείς: Kahl, Fabian, Schalkamp, Ann-Kathrin, Maetzler, Walter, Hansen, Clint, Jonas, Stephan M, Hu, Michele T, Reimer, Lara Marie, Sommerauer, Michael, Gunter, Katarina Mary, Ophey, Anja, Röttgen, Sinah, Razzaque, Jamil, Kufer, Konstantin, Sandor, Cynthia, Fink, Gereon R, Kalbe, Elke
Πηγή: Movement disorders 41(8), 2189 - 2200 (2026). doi:10.1002/mds.70329
Στοιχεία εκδότη: Wiley
Έτος έκδοσης: 2026
Θεματικοί όροι: info:eu-repo/classification/ddc/610, Humans, Parkinson Disease: diagnosis, Parkinson Disease: physiopathology, Prodromal Symptoms, Male, Female, United Kingdom, REM Sleep Behavior Disorder: diagnosis, REM Sleep Behavior Disorder: physiopathology, Wearable Electronic Devices, Middle Aged, Aged, Accelerometry: instrumentation, Germany, Cohort Studies, Movement: physiology
Θέμα γεωγραφικό: DE
Περιγραφή: Models trained on accelerometer data have been proposed for detecting prodromal Parkinson's disease (PD). However, uncertainties in diagnosis timing in the UK Biobank (UKBB) may affect generalizability to other cohorts.The aim of the study was to evaluate the performance of previously published models for prodromal PD detection in other international cohorts.We applied the models to data from German and British cohorts of individuals with isolated or idiopathic rapid eye movement sleep behavior disorder and healthy controls. We compared hourly acceleration patterns and classification performance across cohorts.The British cohort exhibited visually similar activity patterns to UK Biobank but weaker statistical differences and reduced model performance. The German cohort showed no significant group differences and lower performance. No pair of cohorts demonstrated statistical equivalence.Models trained on UK Biobank data may capture early clinical disease rather than universal prodromal markers. Prospective validation in well-characterized cohorts is essential before clinical translation. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Τύπος εγγράφου: article in journal/newspaper
Γλώσσα: English
ISSN: 1531-8257
0885-3185
Relation: info:eu-repo/semantics/altIdentifier/pmid/pmid:42141756; info:eu-repo/semantics/altIdentifier/issn/1531-8257; info:eu-repo/semantics/altIdentifier/issn/0885-3185; https://pub.dzne.de/record/288587
Διαθεσιμότητα: https://pub.dzne.de/record/288587
https://pub.dzne.de/search?p=id:%22DZNE-2026-00914%22
Rights: info:eu-repo/semantics/openAccess
Αριθμός Καταχώρησης: edsbas.29E6C5B2
Βάση Δεδομένων: BASE